What does EC50 describe in pharmacodynamics?

Unlock your potential with the Lock and Key Systems (PY104.16) Test. Utilize interactive quizzes, multiple choice questions, hints, and explanations to master the subject. Prepare efficiently for your certification exam today!

Multiple Choice

What does EC50 describe in pharmacodynamics?

Explanation:
EC50 is the concentration of a drug that produces half of its maximal pharmacodynamic effect. This makes it a measure of potency on the dose–response curve: a lower EC50 means the drug is more potent because less of it is needed to reach 50% of the maximum effect. This value relates to the amount of effect achieved, not to toxicity limits, how fast receptors are occupied, or how tightly the drug binds. The description about the maximum concentration before toxicity refers to toxic or therapeutic ceiling, not the effective concentration on the response curve. Describing the time to reach 50% receptor occupancy covers how quickly receptors are engaged, which is about occupancy kinetics rather than the level of effect. Describing the affinity of the ligand for the receptor concerns binding strength (often KD), not the actual effect level at half-max. In summary, EC50 directly pinpoints the concentration needed to yield half of the maximum response, reflecting potency on the dose–response relationship.

EC50 is the concentration of a drug that produces half of its maximal pharmacodynamic effect. This makes it a measure of potency on the dose–response curve: a lower EC50 means the drug is more potent because less of it is needed to reach 50% of the maximum effect. This value relates to the amount of effect achieved, not to toxicity limits, how fast receptors are occupied, or how tightly the drug binds.

The description about the maximum concentration before toxicity refers to toxic or therapeutic ceiling, not the effective concentration on the response curve. Describing the time to reach 50% receptor occupancy covers how quickly receptors are engaged, which is about occupancy kinetics rather than the level of effect. Describing the affinity of the ligand for the receptor concerns binding strength (often KD), not the actual effect level at half-max. In summary, EC50 directly pinpoints the concentration needed to yield half of the maximum response, reflecting potency on the dose–response relationship.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy